These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 22743248)
1. Icariside II potentiates paclitaxel-induced apoptosis in human melanoma A375 cells by inhibiting TLR4 signaling pathway. Wu J; Guan M; Wong PF; Yu H; Dong J; Xu J Food Chem Toxicol; 2012 Sep; 50(9):3019-24. PubMed ID: 22743248 [TBL] [Abstract][Full Text] [Related]
2. Icariside II induces apoptosis of melanoma cells through the downregulation of survival pathways. Wu J; Xu J; Eksioglu EA; Chen X; Zhou J; Fortenbery N; Wei S; Dong J Nutr Cancer; 2013; 65(1):110-7. PubMed ID: 23368920 [TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway]. Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997 [TBL] [Abstract][Full Text] [Related]
4. A DC-81-indole conjugate agent suppresses melanoma A375 cell migration partially via interrupting VEGF production and stromal cell-derived factor-1α-mediated signaling. Hsieh MC; Hu WP; Yu HS; Wu WC; Chang LS; Kao YH; Wang JJ Toxicol Appl Pharmacol; 2011 Sep; 255(2):150-9. PubMed ID: 21708181 [TBL] [Abstract][Full Text] [Related]
5. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells. Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343 [TBL] [Abstract][Full Text] [Related]
6. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Qu Y; Wang J; Sim MS; Liu B; Giuliano A; Barsoum J; Cui X Breast Cancer Res Treat; 2010 Jun; 121(2):311-21. PubMed ID: 19609669 [TBL] [Abstract][Full Text] [Related]
7. Atractylenolide-I sensitizes human ovarian cancer cells to paclitaxel by blocking activation of TLR4/MyD88-dependent pathway. Huang JM; Zhang GN; Shi Y; Zha X; Zhu Y; Wang MM; Lin Q; Wang W; Lu HY; Ma SQ; Cheng J; Deng BF Sci Rep; 2014 Jan; 4():3840. PubMed ID: 24452475 [TBL] [Abstract][Full Text] [Related]
8. Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8. Sootichote R; Thuwajit P; Singsuksawat E; Warnnissorn M; Yenchitsomanus PT; Ithimakin S; Chantharasamee J; Thuwajit C BMC Cancer; 2018 Feb; 18(1):231. PubMed ID: 29486738 [TBL] [Abstract][Full Text] [Related]
9. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation. Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733 [TBL] [Abstract][Full Text] [Related]
10. Benzyl isothiocyanate (BITC) induces G2/M phase arrest and apoptosis in human melanoma A375.S2 cells through reactive oxygen species (ROS) and both mitochondria-dependent and death receptor-mediated multiple signaling pathways. Huang SH; Wu LW; Huang AC; Yu CC; Lien JC; Huang YP; Yang JS; Yang JH; Hsiao YP; Wood WG; Yu CS; Chung JG J Agric Food Chem; 2012 Jan; 60(2):665-75. PubMed ID: 22148415 [TBL] [Abstract][Full Text] [Related]
11. 3,3'-diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. McGuire KP; Ngoubilly N; Neavyn M; Lanza-Jacoby S J Surg Res; 2006 May; 132(2):208-13. PubMed ID: 16580691 [TBL] [Abstract][Full Text] [Related]
12. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific. Kissel CK; Schadendorf D; Röckmann H Melanoma Res; 2006 Dec; 16(6):527-35. PubMed ID: 17119454 [TBL] [Abstract][Full Text] [Related]
13. Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells. Burgeiro A; Gajate C; Dakir el H; Villa-Pulgarín JA; Oliveira PJ; Mollinedo F Anticancer Drugs; 2011 Jul; 22(6):507-18. PubMed ID: 21527846 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Kuo HC; Lee HJ; Hu CC; Shun HI; Tseng TH Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):55-62. PubMed ID: 16051289 [TBL] [Abstract][Full Text] [Related]
15. Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells. Wang CC; Chiang YM; Sung SC; Hsu YL; Chang JK; Kuo PL Cancer Lett; 2008 Jan; 259(1):82-98. PubMed ID: 18023967 [TBL] [Abstract][Full Text] [Related]
16. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451 [TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of capsaicin-induced apoptosis of human melanoma A375-S2 cells]. Gong XF; Wang MW; Ikejima T Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):401-3. PubMed ID: 16188123 [TBL] [Abstract][Full Text] [Related]
18. Icariside II inhibits cell proliferation and induces cell cycle arrest through the ROS-p38-p53 signaling pathway in A375 human melanoma cells. Wu J; Song T; Liu S; Li X; Li G; Xu J Mol Med Rep; 2015 Jan; 11(1):410-6. PubMed ID: 25333296 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Wang TH; Chan YH; Chen CW; Kung WH; Lee YS; Wang ST; Chang TC; Wang HS Oncogene; 2006 Aug; 25(35):4857-66. PubMed ID: 16547493 [TBL] [Abstract][Full Text] [Related]
20. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis. Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]